Keyphrases
A1 Receptor
9%
Amides
8%
Antidiabetic Drugs
9%
Antihyperglycemic
16%
B Cells
6%
Blood Glucose
6%
Cardiovascular Risk
7%
Clinical Trials
9%
Dapagliflozin
17%
Diabetes
33%
Diabetes Management
10%
Diabetic
16%
Diabetic Mice
8%
Dipeptidyl peptidase-4 (DPP-4)
10%
Dipeptidyl peptidase-IV (DPP-IV)
11%
Fatty Acids
8%
Glucagon
8%
Glucagon-like
24%
Glucose Uptake
8%
Glucose-dependent Insulinotropic Polypeptide
15%
Glucose-lowering Drugs
21%
Glycemic Control
25%
Hemoglobin A1c (HbA1c)
11%
Hyperglycemia
18%
Hypoglycemia
9%
Insulin
41%
Insulin Action
7%
Insulin Release
19%
Insulin Resistance
26%
Insulin Secretion
15%
Insulin Sensitivity
6%
Islet
7%
Metformin
62%
Monocytes
6%
Monotherapy
8%
Obesity
20%
Palmitate
11%
Peroxisome Proliferator-activated Receptor
8%
Placebo
8%
Plasma Glucose
7%
Receptor Agonist
8%
Rosiglitazone
8%
Skeletal muscle
6%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
10%
Thiazolidinediones
13%
Type 1 Diabetes Mellitus (T1DM)
8%
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetes Prevention
11%
Type 2 Diabetic Patients
23%
Weight Loss
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antidiabetic Agent
13%
Cardiovascular Disease
5%
Cardiovascular Risk
5%
Clinical Trial
10%
Dapagliflozin
17%
Diabetes Mellitus
15%
Diabetic Obesity
7%
Dipeptidyl Peptidase IV
8%
Dipeptidyl Peptidase IV Inhibitor
9%
Fatty Acid
7%
Gastric Inhibitory Polypeptide
20%
Glucagon
5%
Glucagon Like Peptide 1 [7-36] Amide
6%
Glucagon-Like Peptide-1
15%
Hemoglobin A1c
12%
Hyperglycemia
17%
Hypoglycemia
10%
Incretin
9%
Insulin Resistance
19%
Metformin
46%
Monotherapy
10%
Non Insulin Dependent Diabetes Mellitus
92%
Ob/Ob Mouse
14%
Palmitic Acid
8%
Peroxisome Proliferator Activated Receptor
6%
Pharmacotherapy
6%
Pioglitazone
5%
Placebo
11%
Receptor
9%
Rosiglitazone
5%
Sibutramine
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
sodium glucose cotransporter-2 inhibitors
6%
Streptozotocin
5%
Sulfonylurea
7%
Tablet
7%
Thiazolidinedione
10%
Medicine and Dentistry
Antidiabetic Agent
9%
Blood Glucose
10%
Cardiovascular Risk
5%
Cardiovascular System
5%
Dapagliflozin
7%
Diabetes
40%
Diabetes Mellitus
11%
Dipeptidyl Peptidase-4 Inhibitor
6%
Drug Therapy
5%
Epithelial Cell
6%
Gastric Inhibitory Polypeptide
6%
Glucagon
6%
Glucagon Like Peptide 1
5%
Glucagon-Like Peptide-1 Agonist
5%
Glucose Uptake
9%
Glycemic
6%
Glycemic Control
19%
Glycon
41%
Hyperglycemia
16%
Hypoglycemia
10%
In Vitro
6%
Incretin
5%
Insulin Release
13%
Insulin Resistance
13%
Leptin
6%
Maturity Onset Diabetes of the Young
69%
Ob/Ob Mouse
6%
Oral Antidiabetic Agent
5%
Patient with Type 2 Diabetes
10%
Receptor
5%
Skeletal Muscle
5%
Sodium Glucose Cotransporter 2 Inhibitor
6%